🇺🇸 FDA
Patent

US 10995071

Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

granted A61KA61K31/415A61P

Quick answer

US patent 10995071 (Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide) held by MEREO BIOPHARMA 1 LIMITED expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MEREO BIOPHARMA 1 LIMITED
Grant date
Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/415, A61P, A61P25/00, A61P29/00